tyk-00540
Small moleculeexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Jan 2, 2024 (NCT06246071)
Timeline
2020s
- Jan 1, 2024
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Cyclin-dependent kinase 6INHIBITOR
CDK6 inhibitor
- Cyclin-dependent kinase 4INHIBITOR
CDK4 inhibitor
- Cyclin-dependent kinase 2INHIBITOR
CDK2 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07104643 | Phase 1/Phase 2 (Phase 2) | Aug 31, 2025 | TYK Medicines, Inc |
| NCT06246071 | Phase 1 | Jan 2, 2024 | TYK Medicines, Inc |
| NCT06950086 | Phase 1/Phase 2 (Phase 2) | Jan 2, 2024 | TYK Medicines, Inc |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| TYK Medicines, Inc | For profit | 3 | 3 | 2 | 2024 |
1 organizations
Page 1 / 1